Labshake search
Citations for Tocris :
401 - 450 of 1908 citations for 6H Pyrazolo 3 4 b pyridin 6 one 3 cyclobutyl 1 2 4 5 tetrahydro 4 methyl 9CI since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Neuroscience 2022Quote: ... and 3) bath application of 1µM DCG-IV (0975, Tocris) at the end of LTP recording significantly reduced the evoked fEPSPs ...
-
bioRxiv - Molecular Biology 2020Quote: ... “CBRa” media consists of cSFDM containing 3 μm CHIR99021 (Tocris), 10 ng/mL recombinant human BMP4 (rhBMP4 ...
-
bioRxiv - Developmental Biology 2020Quote: ... day 3 hPSC-derived NMP-like cells were dissociated using Accutase and re-plated at a density of 37,500-86,000 cells /cm2 on Geltrex (Thermo Fisher)-coated plates directly in N2B27 containing CHIR99021 (3 µM, Tocris) and FGF2 (100 ng/ml ...
-
bioRxiv - Molecular Biology 2020Quote: ... cells were treated with 3 µM of KU60019 (Tocris Bioscience) for 24 hours ...
-
bioRxiv - Animal Behavior and Cognition 2021Quote: ... SCH 23389 (3 mg/ml in saline, Tocris #0925/10) and SKF 38393 (8.41 mg/ml in saline ...
-
bioRxiv - Neuroscience 2020Quote: ... mGluR2/3 antagonist (1μM LY341495, Tocris Bio-Techne, Minneapolis, MN) and DGK inhibitor II (100 μM R59949 ...
-
bioRxiv - Evolutionary Biology 2021Quote: ... and 3 µM GSK3 inhibitor CHIR99021 (Tocris, Cat. No. 4423). mESC medium was made from Knockout DMEM (Gibco ...
-
bioRxiv - Developmental Biology 2023Quote: ... The N2B27 medium was supplemented with CHIR (3 μM, Tocris), FGF2 (20 ng/ml ...
-
bioRxiv - Cancer Biology 2023Quote: ... 3 μM of CHIR99021 (Tocris Bioscience, Minneapolis, USA, Cat#4423) and 1 μM of PD0325901 (Selleckchem ...
-
bioRxiv - Biochemistry 2024Quote: ... Exendin-3 (9-39) amide (2081) was purchased from Tocris. Recombinant GDF15 (957-GD ...
-
bioRxiv - Neuroscience 2023Quote: ... N-Methyl-D-Aspartate (NMDA, Tocris®). 7-(Hydroxyimino)cyclopropa[b]chromen-1a-carboxylate ethyl ester (CPCCOEt ...
-
bioRxiv - Neuroscience 2023Quote: ... was selected by qualifying the presence of innervated cancer spheroids at various heights within the gel layer before stimulation with either 4 µM Bradykinin (Tocris/Biotechne, #3004) or 1 µM Capsaicin (Tocris/Biotechne ...
-
bioRxiv - Immunology 2021Quote: ... cells were stimulated with HDM or the known AhR agonist FICZ (5,11-Dihydroindolo[3,2-b]carbazole-6-carboxaldehyde, Tocris Bioscience ...
-
bioRxiv - Biochemistry 2023Quote: ... 5% CO2 with either DMSO or MLi-2 (Tocris; 2 μM) for 1 hour ...
-
bioRxiv - Cell Biology 2020Quote: ... cells were stained with 3 µg/mL FM4-64 (Tocris 5118) in BY-2 media then imaged with a 560 nm diode-pumped solid-state laser (Melles Griot ...
-
bioRxiv - Neuroscience 2023Quote: ... the NMDA antagonist AP5 (3 μg/0.5 μl/side; Tocris Bioscience) to the DMS ...
-
bioRxiv - Bioengineering 2023Quote: ... or phosphoinositide 3-kinase (PI3K) (LY 294002, 10 µM, Tocris, UK) for 4 days ...
-
bioRxiv - Bioengineering 2023Quote: ... A staining solution was prepared with 3 µM Hoechst 33342 (Tocris), 4 µM calcein-AM (eBioscience) ...
-
bioRxiv - Neuroscience 2021Quote: ... 6-Isopropoxy-9-xanthone-2-carboxylic acid (AH6809, 10 µM, Tocris); N-(piperidin-1-yl)-5-(4-iodophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide (AM251 ...
-
bioRxiv - Neuroscience 2022Quote: ... injected with saline (control) or a range of doses (0.3, 1, 3, or 10mg/kg) of (R)-CPP (Tocris Bioscience ...
-
bioRxiv - Neuroscience 2022Quote: ... or 20 μM 2-methylthyo-adenosine-5’-triphosphate (2-MeSATP, Tocris, 1062) over a 5-min period ...
-
bioRxiv - Neuroscience 2021Quote: ... In every animal a volume of 500nl of CNO (3 µM, Tocris) was infused at a rate of 0.5µl/min to target the PAG ...
-
bioRxiv - Genomics 2020Quote: ... ‘‘CBRa’’ medium consists of cSFDM base supplemented with 3 µM CHIR99021 (Tocris), 10 ng/mL recombinant human BMP4 (rhBMP4 ...
-
bioRxiv - Neuroscience 2021Quote: ... we added the CB1 receptor antagonist AM-251 (3 µM; Tocris, UK), or the NO synthase inhibitor L-NAME (200 µM ...
-
bioRxiv - Neuroscience 2020Quote: ... and the glutamate receptor antagonist kynurenic acid (3 mM KynA, Tocris Bioscience) was included in the external solution to isolate GABA currents ...
-
bioRxiv - Neuroscience 2020Quote: ... the IS was supplemented with 3 mg/ml biocytin (Tocris, Bristol, UK) or 1.5 mg/ml neurobiotin (Vector Laboratories ...
-
bioRxiv - Genomics 2019Quote: ... and 12 uM of the GSK-3 inhibitor CHIR99021 trihydrochloride (Tocris, 4953). This medium was changed to base heart media 24 hours later (Day 1) ...
-
bioRxiv - Genomics 2021Quote: ... and 12uM of GSK-3 inhibitor CHIR99021 trihydrochloride (4953, Tocris, Bristol, UK). “Heart media” is composed of RPMI (15-040-CM ...
-
bioRxiv - Neuroscience 2023Quote: ... Antagonists included the GABA-A blocker bicuculline methiodide (BCC, 3 μM, Tocris) by itself or ...
-
bioRxiv - Cell Biology 2023Quote: ... Media was then changed to cSFDM with 3 uM CHIR99021 (“C”; Tocris), recombinant human BMP4 (10 ng/ml ...
-
bioRxiv - Bioengineering 2023Quote: ... A83-01 (PeproTech, cat# 9094360 or Tocris, cat# 2939, 0.1-3 µM) and the impedance of monolayers was measured at 10 kHz at every 5 min for 48-96 h ...
-
bioRxiv - Neuroscience 2021Quote: ... an agonist of group II metabotropic glutamate receptors (mGluR2/3) that reduces release probability in mossy fiber terminals (1 μM, Tocris)(Kamiya et al. ...
-
bioRxiv - Developmental Biology 2022Quote: ... and 1% Pen/Strep) +2iLIF (10 ng/ml leukemia inhibitory factor + 3 μM CHIR99021 + 1 μM PD0325901 from Tocris, Cat. # 4423 and 4192, respectively). The cells were grown on 0.1% gelatin-coated dishes and usually seeded at a density of 0.5–1.5 × 104/cm2 ...
-
bioRxiv - Neuroscience 2019Quote: ... and 50 µM D-2-amino-5-phosphonovaleric acid (D-AP-5; Tocris) to isolate synaptic inhibitory transmission ...
-
bioRxiv - Cancer Biology 2021Quote: ... L-DOPA methyl ester (300 mg/kg, Tocris # 0455) and carbidopa (75 mg/kg ...
-
bioRxiv - Neuroscience 2021Quote: ... NMDA (N-Methyl-D-aspartic acid 10μM Tocris Bioscience), siRNAs (Dharmacon/Horizon ...
-
bioRxiv - Neuroscience 2023Quote: ... 5-HT7 receptor agonist (10-5M AS-19, Tocris, CAS:1000578-26-6). The stock solutions of these drugs were diluted in extracellular physiological saline which contained ...
-
bioRxiv - Neuroscience 2023Quote: ... 5-HT7 receptor antagonist (10-5M Sb 258719, Tocris, CAS:1217674-10-6), 5-HT7 receptor agonist (10-5M AS-19 ...
-
bioRxiv - Cell Biology 2021Quote: Receptors were stimulated as follows: human Angiotensin 1 receptor (AT1R) with Angiotensin II (AngII; Tocris 4474-91-3, in measuring buffer), human β2 adrenergic receptor (β2ADR ...
-
bioRxiv - Neuroscience 2023Quote: ... 5-(4-Bromophenyl)-3-(1,2-dihydro-6-methyl-2-oxo-4-phenyl-3-quinolinyl)-4,5-dihydro-γ-oxo-1H-pyrazole-1-butanoic acid (DQP 1105, 10 μM dissolved in DMSO; Tocris Bioscience), or 6-Cyano-7-nitroquinoxaline-2,3-dione disodium (CNQX ...
-
bioRxiv - Developmental Biology 2021Quote: ... which consists of a N2B27 basal medium supplemented with 3 µM CHIR99021 (Tocris), 1µM PD0325901 (SelleckChem ...
-
bioRxiv - Cancer Biology 2020Quote: ... established tumorspheres were treated with either 0.5 µM or 3 µM CHIR99021 (Tocris) for 5 days ...
-
bioRxiv - Neuroscience 2021Quote: ... The craniotomy was then covered with 3% agar (MilliporeSigma) dissolved in aCSF (TOCRIS). The agar was prevented from drying out by covering it with silicone oil ...
-
bioRxiv - Neuroscience 2023Quote: ... The craniotomy was then covered with 3% agar (MilliporeSigma) dissolved in aCSF (TOCRIS). The agar was covered with silicone oil (60,000 centistokes ...
-
bioRxiv - Developmental Biology 2024Quote: ... This CBRa media consists of cSFDM containing 3 μm CHIR99021 (Tocris, No.4423), 10 ng/mL rhBMP4 (R&D ...
-
bioRxiv - Neuroscience 2020Quote: ... They were left drug-free for 3 weeks before chronic daily treatment with vehicle (NaCl 0.9%) or VU0155041 (Tocris, Bristol, UK; 2.5 or 5 mg/kg, i.p.) started ...
-
bioRxiv - Neuroscience 2021Quote: ... N-methyl-D-aspartic acid (NMDA, 10 μM; Tocris 0114) or kainic acid (Tocris ...
-
bioRxiv - Neuroscience 2019Quote: ... D- (-)-2-Amino-5-phosphonopentanoic acid (D-AP5, Tocris) and STR were added to the bath solution to block AMPA ...
-
bioRxiv - Cell Biology 2021Quote: ... L-2-amino-5-phosphonovaleric acid (AP5, Tocris Bioscience) were included in the bath solution to prevent recurrent activities.
-
bioRxiv - Neuroscience 2022Quote: ... and d-(−)-2-amino-5-phosphonopentanoic acid (APV, Tocris) were added to the ACSF ...